EE101 Comparison of Two French Cost-Effectiveness Opinions for the Same First-Line Treatment Combination in Renal Cell Carcinoma
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.353
https://www.valueinhealthjournal.com/article/S1098-3015(22)02557-8/fulltext
Title :
EE101 Comparison of Two French Cost-Effectiveness Opinions for the Same First-Line Treatment Combination in Renal Cell Carcinoma
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02557-8&doi=10.1016/j.jval.2022.09.353
First page :
Section Title :
Open access? :
No
Section Order :
12166